Colorectal Carcinoma: Is There Any Correlation between Her2/neu Expression, Ki-67 Score, and Tumor Budding and Clinicopathological Parameters?-A Prospective Institution-Based Study

被引:0
|
作者
Khan, Susnata [1 ]
Dasgupta, Senjuti [2 ]
Deb, Asit Ranjan [3 ]
机构
[1] Midnapore Med Coll & Hosp, Dept Pathol, Midnapore, West Bengal, India
[2] Med Coll, Dept Pathol, Kolkata, West Bengal, India
[3] Med Coll, Dept Radiotherapy, Kolkata, West Bengal, India
关键词
colorectal carcinoma; Her2/neu; Ki-67; tumor budding; tumor-infiltrating lymphocytes; INFILTRATING LYMPHOCYTES; CANCER;
D O I
10.1055/s-0044-1789276
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives Colorectal cancer is one of the most frequent cancers worldwide and is still a major cause of cancer mortality. Her2/neu, Ki67 score, and tumor budding are independent prognostic factors in colorectal carcinomas. The objectives of the study were to evaluate Her2/neu expression, Ki67 score, and tumor budding index at invasive margin in colorectal carcinoma and find out their possible correlations with different clinicopathological factors. Materials and Methods An institution-based observational cross-sectional study was conducted for 18 months. Forty-one patients with histologically proven diagnosis of colorectal carcinoma were included. Histopathological and immunohistochemical analyses (Her2/neu and Ki-67) of each case were done. Statistical Analysis Data analysis was done using the SPSS software. Results A significant correlation was found between tumor budding status and pathological T stage, Dukes' and American Joint Committee on Cancer stages, and between tumor-infiltrating lymphocytes status and Ki-67 expression status (p < 0.05). Conclusion The prognostic importance of tumor budding in colorectal carcinoma is very clear. Considering the small sample size of the present study, the prognostic values of Her2/neu and Ki-67 are required to be explored further in larger cohorts in the future.
引用
收藏
页数:5
相关论文
共 35 条
  • [31] Correlation between Standardized Uptake Value of [18F]FDG and Hormone Receptor Status, HER2 Status and Ki-67 Proliferation Index in Patients with Invasive Ductal Carcinoma of the Breast: Preliminary Results
    Chiacchio, S.
    AlSharif, A.
    Tredici, M.
    Puccini, G.
    Fustaino, L.
    Ghilli, M.
    Ali, R. Sheikh
    Juweid, M.
    Margotti, S.
    Volterrani, D.
    Marini, C.
    Roncella, M.
    Mariani, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S399 - S399
  • [32] Analysis of HER-2/neu expression and gene amplification in 1020 infiltrating breast carcinomas by IHC and CISH.: Correlation with tumor type, histological grade, lymph node status and ERα, PgR, p53 and ki-67 expression the hellenic multicenter study
    Valavanis, Christos
    Koutsoubi, Katerina
    Kouneli, Sofia
    Kapranos, Nikiforos
    Sotiropoulou, Maria
    Patakiouta, Frida
    Trihia, Helen
    Morphopoulos, George
    Papaspyrou, Irene
    Georgiadou, Elisabeth
    Toliou, Theofani
    Markaki, Sofia
    Bairaktari, Efi
    Apostolikas, Nikiforos
    Arapantoni-Dadioti, Petroula
    VIRCHOWS ARCHIV, 2007, 451 (02) : 147 - 147
  • [33] Population-based estimate for the correlation of the Oncotype Dx Breast Recurrence Score® result and Ki-67 IHC MIB-1 pharmDx in HR+, HER2−, node-positive early breast cancer
    Michael Crager
    Sameera R. Wijayawardana
    Aaron M. Gruver
    Andrea Blacklock
    Christy Russell
    Frederick L. Baehner
    Francisco Sapunar
    Breast Cancer Research, 24
  • [34] PROGNOSTIC VALUE OF BREAST CANCER SUBTYPES BASED ON ER/PR, HER2 EXPRESSION AND KI-67 INDEX IN WOMEN RECEIVED ADJUVANT THERAPY AFTER CONSERVATIVE SURGERY FOR EARLY STAGES BREAST CANCER A RETROSPECTIVE CLINICAL STUDY
    Fouda, MennaAllah
    BREAST, 2018, 41 : S20 - S20
  • [35] Correlation among 16 biological factors [p53, p21waf1, MIB-1 (Ki-67), p16INK4A, cyclin D1, E-cadherin, Bcl-2, TNF-α, NF-κB, TGF-β, MMP-7, COX-2, EGFR, HER2/neu, ER, and HIF-1α] and clinical outcomes following curative chemoradiation therapy in 10 patients with esophageal squamous cell carcinoma
    Shibata-Kobayashi, Shino
    Yamashita, Hideomi
    Okuma, Kae
    Shiraishi, Kenshiro
    Igaki, Hiroshi
    Ohtomo, Kuni
    Nakagawa, Keiichi
    ONCOLOGY LETTERS, 2013, 5 (03) : 903 - 910